CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions		Total	10% Series A Cumulative Perpetual Preferred Stock	Preferred Stock	Preferred Stock 10% Series A Cumulative Perpetual Preferred Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital 10% Series A Cumulative Perpetual Preferred Stock	Accumulated (Deficit)	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019		$ (23.2)							$ (23.2)
Balance, shares at Dec. 31, 2019						7,300,000
Net income (loss)		(24.0)							(24.0)
Stock issued		4.0	$ 28.2				$ 4.0	$ 28.2
Stock issued, shares					1,200,000	507,143
Opening deferred tax liabilities under reverse recapitalization		(6.2)							(6.2)
Equity infusion from reverse recapitalization, net of transaction costs		175.7					175.7
Equity infusion from reverse recapitalization, net of transaction costs, shares						21,911,359
Shares issued upon settlement of equity-linked incentive plan		3.1					3.1
Shares issued upon settlement of equity-linked incentive plan, shares						300,000
Disgorgement of short swing profits		1.6					1.6
Stock-based compensation		3.6					3.6
Stock-based compensation, share						390,000
Shares issued for acquisition		6.2							6.2
Repurchases of common stock		(5.9)								$ (5.9)
Repurchases of common stock, shares						(390,000)
Balance at Dec. 31, 2020		156.9					216.2		(53.4)	(5.9)
Balance, shares at Dec. 31, 2020				1,200,000		30,018,502
Net income (loss)		(20.8)							(20.8)
Dividends on preferred stock		(2.6)							(2.6)
Stock-based compensation		1.2					1.2
Stock-based compensation, share						65,000
Warrants exchanged into common stock						2,279,874
Balance at Dec. 31, 2021		134.7					217.4		(76.8)	(5.9)
Balance, shares at Dec. 31, 2021				1,200,000		32,363,376
Net income (loss)		9.3							9.3
Opening deferred tax liabilities under reverse recapitalization		(2.7)					(2.7)
Dividends on preferred stock		(3.0)							3.0
Dividends on common stock		(3.7)							3.7
Stock-based compensation		2.7					(2.7)
Stock-based compensation, share						90,649
Foreign currency translation adjustments		(1.5)									$ (1.5)
Change in fair value of derivatives, net of tax		(1.4)									(1.4)
Shares issued for acquisition shares						212,400
Shares issued for acquisition		2.7					2.7
Repurchases of common stock, shares	[1]					(472,182)
Balance at Dec. 31, 2022		$ 139.8					$ 222.8		$ (74.2)	$ (5.9)	$ (2.9)
Balance, shares at Dec. 31, 2022				1,200,000		32,194,243

[1] Correction of previously disclosed shares repurchased in 2020, not previously reported as a reduction of common stock shares outstanding. Amount is immaterial to the consolidated financial statements.